News tagged with astrazeneca

Related topics: food and drug administration

AstraZeneca profits tumble in third quarter

British pharmaceuticals group AstraZeneca announced on Thursday a slump in quarterly profits, in part on higher investment costs, but raised its outlook for full-year revenues.

Nov 06, 2014
popularity not rated yet | comments 0

Pfizer underscores UK commitments in memo (Update)

Pfizer Inc. has sought to allay concerns over its proposed $106 billion takeover offer of Anglo-Swedish pharmaceuticals firm AstraZeneca, insisting that its promises will be legally binding.

May 12, 2014
popularity not rated yet | comments 0

AstraZeneca fends off Pfizer with new growth plan

AstraZeneca on Tuesday outlined plans to make sales jump over the next decade, an effort to persuade shareholders the drug maker can do well as an independent company, rather than get bought out by rival ...

May 06, 2014
popularity not rated yet | comments 0

New clinical trial launched for advance lung cancer

Cancer Research UK is partnering with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung cancer – marking a new era of research into personalised medicines ...

Apr 17, 2014
popularity 5 / 5 (1) | comments 0

AstraZeneca

AstraZeneca plc (LSE: AZN, OMX: AZN, NYSE: AZN), is a large Anglo-Swedish pharmaceutical company formed on 6 April 1999 by the remerger of Swedish Astra AB and British Zeneca Group plc. Zeneca had been part of Imperial Chemical Industries, as 3 divisions that were spun off from ICI on 1 June 1993. The Company is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.

This text uses material from Wikipedia licensed under CC BY-SA